TY - JOUR
T1 - Screening Embryos for Polygenic Conditions and Traits
T2 - Ethical Considerations for an Emerging Technology
AU - Lázaro-Muñoz, Gabriel
AU - Pereira, Stacey
AU - Carmi, Shai
AU - Lencz, Todd
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2021
Y1 - 2021
N2 - (Abstracted from Genet Med 2021;23:432-434) Polygenic embryo screening (PES) uses polygenic risk scores (PRSs) to estimate risk for complex disorders and traits as a part of preimplantation genetic testing (PGT). Preimplantation genetic testing has been used for many years in order to avoid transferring embryos that have aneuploidies or single gene Mendelian disorders.
AB - (Abstracted from Genet Med 2021;23:432-434) Polygenic embryo screening (PES) uses polygenic risk scores (PRSs) to estimate risk for complex disorders and traits as a part of preimplantation genetic testing (PGT). Preimplantation genetic testing has been used for many years in order to avoid transferring embryos that have aneuploidies or single gene Mendelian disorders.
UR - http://www.scopus.com/inward/record.url?scp=85113423282&partnerID=8YFLogxK
U2 - 10.1212/01.CON.0000771668.22235.98
DO - 10.1212/01.CON.0000771668.22235.98
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???
AN - SCOPUS:85113423282
SN - 0029-7828
VL - 76
SP - 458
EP - 459
JO - Obstetrical and Gynecological Survey
JF - Obstetrical and Gynecological Survey
IS - 8
ER -